Mississippi House Bill HB563

Mississippi 2026 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26
• Engrossed: 2/11/26
• Refer: 2/17/26
• Failed: 3/11/26

Caption

Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling.

Impact

If enacted, HB563 will directly affect the state's approach to psilocybin, suggesting a progressive stance on emerging therapeutic options related to mental health. The bill's automatic scheduling provision reflects a recognition of changing perspectives on such substances, potentially influencing the broader legal and medical landscape. This may pave the way for research, medicinal use, and legislative frameworks to support therapeutic applications of psilocybin within Mississippi.

Summary

House Bill 563 proposes the automatic scheduling of psilocybin as a controlled substance following any changes at the federal level. This legislation recognizes the increasing interest in psilocybin, particularly in contexts related to mental health treatments and therapy. By scheduling it automatically, the state aims to stay aligned with federal guidelines regarding its categorization, thus simplifying management and legal compliance regarding its use and distribution.

Contention

Discussions around HB563 may involve concerns regarding public safety and the implications of legalizing or promoting psychedelics for recreational or therapeutic use. Proponents argue the therapeutic benefits of psilocybin, while opponents may raise issues regarding the potential for abuse, public health implications, and the need for further studies into its efficacy and safety. Moreover, aligning state law with federal regulations could lead to debates about the autonomy of state legislation versus federal oversight.